首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1374799

全球微电子医疗植入物市场-2023-2030

Global Microelectronic Medical Implants Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

个人化医疗的发展正在推动对更复杂的医疗设备的需求，包括微电子医疗植入物。远端患者监测的不断增长趋势正在推动对具有无线通讯功能的微电子医疗植入物的需求。

随着微电子技术的不断发展，它在医疗领域的应用越来越多。植入式医疗设备不断扩展到新型疗法，提供了越来越多的药物替代品。心律管理产品是最常见的，应用于心律调节、去颤和心臟再同步。新应用包括帕金森氏症治疗、疼痛管理、胃酸逆流监测器和晕厥监测器。

此外，微电子医疗植入物市场受到多种因素的推动，例如主要参与者推出新设备、医疗植入物的技术进步以及新兴经济体医疗保健支出的增加为微电子医疗植入物製造商提供了巨大的成长机会。

动力学

心血管疾病盛行率上升

冠状动脉疾病、心律不整和心臟衰竭等心血管疾病通常需要心律调节器、除颤器和心臟监视器等植入式装置。这些疾病的日益普及直接增加了对心血管植入物的需求。

例如，根据美国疾病管制与预防中心更新的 2023 年情况说明书，心臟病是美国男性、女性以及大多数种族和民族群体个人的主要原因。在美国，每 33 秒就有一人死于心血管疾病。

2021 年，美国约有 695,000 人死于心臟病，占死亡人数的五分之一。 2018年至2019年，美国在心臟病方面的支出约为2.399亿美元。这涵盖了医疗保健服务、药物的费用以及因死亡而造成的生产力损失。

科技进步的崛起

治疗性神经植入物产生电刺激，使神经元恢復正常状态，类似大脑节律器。这些植入物使用 CMOS 技术整合到微型硅晶片中，从而减小了设备的物理尺寸和功耗。

植入物成本高

利用微电子技术开发和测试植入式医疗设备可能非常昂贵，限制了某些患者和医疗保健系统对这些设备的负担能力和可近性。

人工耳蜗手术是一种将小型复杂电子设备放置在耳后皮肤下的医疗手术。这种电子设备[人工耳蜗]有助于刺激听觉神经，使患者能听到声音。印度人工耳蜗的费用从 65,870 印度卢比到 430,000 印度卢比不等，最高可达 873,600 印度卢比。平均成本也较高。

As microelectronic technology continues to evolve, it is finding increased applications in the medical sector. Implantable medical devices are continuing to branch out to new types of therapies, posing a continuously growing number of alternatives to medication. Cardiac rhythm management products are the most common, with applications in pacing, defibrillation, and heart resynchronization. New applications include Parkinson's treatment, pain management, acid reflux monitors and syncope monitors.

Furthermore, the microelectronic medical implants market is driven by various factors like, new device launches by key players, technological advancements in medical implants, and increasing healthcare spending in emerging economies presents significant growth opportunities for microelectronic medical implant manufacturers.

Dynamics

Rise in the Prevalence of Cardiovascular Diseases

Cardiovascular diseases, such as coronary artery disease, arrhythmias, and heart failure, often require implantable devices like pacemakers, defibrillators, and cardiac monitors. The growing prevalence of these conditions directly increases the demand for cardiovascular implants.

For instance, according to the Centers for Disease Control and Prevention's updated factsheet 2023, heart disease is the main cause of death in the United States for men, women, and individuals of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 33 seconds.

Approximately 695,000 persons in the United States died from heart disease in 2021, accounting for one out of every five fatalities. From 2018 to 2019, the United States spent around $239.9 Million on heart disease. This covers the expense of healthcare services, medications, and lost productivity as a result of mortality.

Rise in the Technological Advancements

Therapeutic neural implants produce electrical stimulation to restore neurons to normal conditions, similar to a pacemaker for the brain. These implants are integrated into miniature silicon chips using CMOS technology, reducing the device's physical dimensions and power consumption.

High Cost of Implants

Developing and testing implantable medical devices with microelectronics technology can be expensive, limiting the affordability and accessibility of these devices for some patients and healthcare systems.

Cochlear Implant surgery is a medical procedure in which a small, complex electronic device is placed under the skin behind the ear. This electronic device [Cochlear implant] helps stimulate the auditory nerves and allows the patient to hear. The cost of a Cochlear Implant in India ranges from INR 65,870 to INR 4,30,000, with the maximum cost reaching INR 8,73,600. The average cost is also higher.

Segment Analysis

The global microelectronic medical implants market is segmented based on device type, application, technology, end-user and region.

The Pacemakers & Defibrillators Segment From the Device Type Segment Accounted For Approximately 41.7% of Microelectronic Medical Implants Share

The pacemakers & defibrillators segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. The computer circuits perform the functions of monitoring the patient's underlying heart rhythm and delivering an electrical signal to cause the heart to beat at the desired rate. Microelectronics plays a crucial role in pacemakers, a small, battery-powered device that controls the heart's rhythm. It requires precision manufacturing for proper function and has made pacemakers smaller, durable, and longer-lasting, making them more accessible and affordable.

For instance, in February 2023 Medtronic announced clinical data demonstrating significant improvements in Afib detection using the Reveal Linq. The study compared the Reveal Linq insertable cardiac monitor (ICM) to patients randomized to standard of care. Those patients did not receive continuous long-term monitoring.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors such as a rise in the number of FDA approvals for different products in the U.S., an increase in the prevalence of cardiac diseases, and the presence of favourable government policies in the region.

For instance, in August 2023 BIOTRONIK, a leader in implantable medical device technology, stated its first US implantation of the new Amvia Edge pacemaker.

Competitive Landscape

The major global players in the market include: Biotronik, Boston Scientific Corporation, Abbott Laboratories, ZOLL Medical Corporation, Schiller, Medtronic, Lepu Medical, ZimVie, Stryker, Avantor, Inc. and among others

Key Developments

In May 2023 Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.
In August 2021, Abbott Laboratories received FDA approval for its Infinity DBS system, a deep brain stimulation device used to treat Parkinson's disease and essential tremors. The device features advanced stimulation technology that allows for personalized therapy and real-time patient feedback.
In September 2021, LivaNova announced the launch of its next-generation Vagus Nerve Stimulation (VNS) therapy system for the treatment of epilepsy. The system features advanced simulation technology and offers patients a personalized approach to therapy.

COVID-19 Impact Analysis

The pandemic has resulted in a surge in demand for medical devices such as personal protective equipment, ventilators, and general hospital supplies. On the other hand, the postponement and cancellation of non-essential and elective procedures have impacted financially the manufacturers focusing on devices used in such procedures. The pandemic has also affected the supply chains of medical devices, including microelectronics, which may have caused initial shortages of deliveries.

Why Purchase the Report?

To visualize the global microelectronic medical implants market segmentation based on device type, application, technology, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global microelectronic medical implants market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global microelectronic medical implants market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by Technology
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Atrial Fibrillation
  - 4.1.1.2. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Tedious And Outdated Holter ECG Analysis
- 4.1.3. Opportunity
  - 4.1.3.1. Rise in the Product Launches in Emerging Markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. Pacemakers & Defibrillators*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Neurostimulators
7.4. Implantable Drug Pumps
7.5. Spinal Fusion Stimulators
7.6. Cochlear Implants
7.7. Ocular Implants
7.8. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Neurology
8.4. Ophthalmology
8.5. Orthopedics
8.6. Others

9. By Technology

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.1.2. Market Attractiveness Index, By Technology
9.2. RF Technology*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Sensors
9.4. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Biotronik *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Boston Scientific Corporation
13.3. Abbott Laboratories
13.4. ZOLL Medical Corporation
13.5. Schiller
13.6. Medtronic
13.7. Lepu Medical
13.8. ZimVie
13.9. Stryker
13.10. Avantor, Inc

LIST NOT EXHAUSTIVE